Hopp til innhold

Get alerts of updates about «Risk Assessment and Regulations of Nanomaterials in Norway and Russia»

How often would you like to receive alerts from fhi.no? (This affects all your alerts)

The email address you register will only be used to send you these alerts. You can cancel your alerts and delete your email address at any time by following the link in the alerts you receive.
Read more about the privacy policy for fhi.no

You have subscribed to alerts about:

  • Risk Assessment and Regulations of Nanomaterials in Norway and Russia

Report

Risk Assessment and Regulations of Nanomaterials in Norway and Russia

Published

Den økende bruken av nanoteknologi i forbruksprodukter, til industrielle formål og innen medisin, har ført til teknologiske fremskritt som kan gi stor økonomisk gevinst. The increasing use of nanotechnology in consumer products, for industrial purposes and in medicine has led to technological advances that can provide great financial gains.

Den økende bruken av nanoteknologi i forbruksprodukter, til industrielle formål og innen medisin, har ført til teknologiske fremskritt som kan gi stor økonomisk gevinst. The increasing use of nanotechnology in consumer products, for industrial purposes and in medicine has led to technological advances that can provide great financial gains.


About this publication

  • Year: May 2016
  • By: Norwegian Institute of Public Health
  • Authors Glushkova, Refsnes, Låg, Khlebnikova and Schwarze.
  • ISBN (digital): 978-82-8082-728-9
Order

Download:

Summary

Released nanoparticles could potentially cause injury. For this reason, it is important to conduct risk assesments in the development of nanotechnology, both in terms of production and in use of nanomaterials. This report is based on a joint seminar in St Petersburg in 2015, where Russian and Norwegian health officials examined the regulation of nanomaterials, identifying similarities and differences in the way it is done in the two countries.